California State Teachers Retirement System (CalSTRS)’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-96,236
Closed -$2.32M 3296
2023
Q1
$2.32M Buy
96,236
+3,765
+4% +$47.2K ﹤0.01% 1388
2022
Q4
$977K Buy
92,471
+22,342
+32% +$180K ﹤0.01% 1923
2022
Q3
$316K Buy
70,129
+1,017
+1% +$4.63K ﹤0.01% 2516
2022
Q2
$276K Buy
69,112
+3,883
+6% +$18.4K ﹤0.01% 2587
2022
Q1
$477K Sell
65,229
-5,347
-8% -$32K ﹤0.01% 2422
2021
Q4
$397K Buy
70,576
+1,691
+2% +$10.7K ﹤0.01% 2588
2021
Q3
$441K Sell
68,885
-7,585
-10% -$48.7K ﹤0.01% 2498
2021
Q2
$645K Sell
76,470
-3,565
-4% -$28.8K ﹤0.01% 2497
2021
Q1
$840K Buy
80,035
+7,999
+11% +$113K ﹤0.01% 2251
2020
Q4
$1.22M Hold
72,036
﹤0.01% 1918
2020
Q3
$924K Buy
72,036
+8,140
+13% +$103K ﹤0.01% 1909
2020
Q2
$902K Buy
+63,896
New +$807K ﹤0.01% 1904

Other funds holding PRVB

California State Teachers Retirement System (CalSTRS)'s PRVB Position: Q2 2023 in Review

California State Teachers Retirement System (CalSTRS) sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 96,236 shares — an estimated $2.32M sold.

California State Teachers Retirement System (CalSTRS) first reported a position in PRVB in Q2 2020 and held it in 12 quarters. The position peaked at $2.32M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 96,236 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $2.32M.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Provention Bio, Inc. Common Stock in Q2 2020 and held it in 12 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Provention Bio, Inc. Common Stock position peaked at $2.32M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2023, filed 21 Aug 2023.